The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
pembrolizumab and berahyaluronidase alfa · Injection, Solution
2 marketed package NDCs · 1 active manufacturer
Common questions
- Is Pembrolizumab and berahyaluronidase alfa in shortage right now?
- No. FDA does not currently list Pembrolizumab and berahyaluronidase alfa in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Pembrolizumab and berahyaluronidase alfa?
- 1 company has marketed Pembrolizumab and berahyaluronidase alfa in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.